Literature DB >> 9473734

Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis.

L Sun1, A M Hui, Y Kanai, M Sakamoto, S Hirohashi.   

Abstract

The present study was designed to determine whether changes in DNA methyltransferase (DNA MTase) expression are involved in hepatocarcinogenesis. We examined DNA MTase expression in normal liver tissue (with no remarkable histological findings), liver tissue showing chronic hepatitis or cirrhosis, which are generally thought to be precancerous conditions, and hepatocellular carcinomas (HCCs) using the reverse-transcriptase polymerase chain reaction assay. DNA MTase mRNA levels were significantly higher in liver tissue showing chronic hepatitis and cirrhosis (DNA MTase mRNA/beta-actin mRNA ratio = 0.30 +/- 0.22, n = 24, P < 0.01) than in normal liver tissue either from patients with liver metastatic lesions of colonic cancer (0.14 +/- 0.05, n = 6) or from patients with HCCs (0.16 +/- 0.07, n = 3). DNA MTase mRNA levels were even higher in HCC tissue (0.34 +/- 0.18, n = 29). These results suggest that increased DNA MTase expression may be an early event during hepatocarcinogenesis. DNA MTase is a potential target for HCC preventive therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9473734      PMCID: PMC5921336          DOI: 10.1111/j.1349-7006.1997.tb00345.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


hepatocellnlar carcinoma meth‐yltransferase reverse‐transcriptase polymerase chain reaction
  33 in total

Review 1.  DNA methylation errors and cancer.

Authors:  P A Jones
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

2.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.

Authors:  S Ramchandani; A R MacLeod; M Pinard; E von Hofe; M Szyf
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.

Authors:  M Makos; B D Nelkin; R E Reiter; J R Gnarra; J Brooks; W Isaacs; M Linehan; S B Baylin
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

4.  Inactivation of p16INK4 in hepatocellular carcinoma.

Authors:  A M Hui; M Sakamoto; Y Kanai; Y Ino; M Gotoh; J Yokota; S Hirohashi
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

5.  Increased cytosine DNA-methyltransferase activity during colon cancer progression.

Authors:  J P Issa; P M Vertino; J Wu; S Sazawal; P Celano; B D Nelkin; S R Hamilton; S B Baylin
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

6.  Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis.

Authors:  A R MacLeod; M Szyf
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

7.  DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.

Authors:  T L Kautiainen; P A Jones
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

8.  Expression of DNA methyltransferase in LEC rats during hepatocarcinogenesis.

Authors:  E Miyoshi; S K Jain; T Sugiyama; J Fujii; N Hayashi; H Fusamoto; T Kamada; N Taniguchi
Journal:  Carcinogenesis       Date:  1993-04       Impact factor: 4.944

9.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Authors:  M M Wales; M A Biel; W el Deiry; B D Nelkin; J P Issa; W K Cavenee; S J Kuerbitz; S B Baylin
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

10.  Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis.

Authors:  Y Kanai; S Ushijima; H Tsuda; M Sakamoto; T Sugimura; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1996-12
View more
  20 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  Does oxidative stress participate in the development of hepatocellular carcinoma?

Authors:  Yutaka Sasaki
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

3.  DNA methyltransferase expression in odontogenic cysts and tumours.

Authors:  Carolina Cavaliéri Gomes; João Artur Ricieri Brito; Carlos Inácio Andrade; Ricardo Santiago Gomez
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

4.  Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells.

Authors:  Karolina Skowronski; Sonam Dubey; David Rodenhiser; Brenda Coomber
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

Review 5.  Clinical implications of DNA methylation in hepatocellular carcinoma.

Authors:  Eric L Sceusi; David S Loose; Curtis J Wray
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

6.  Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.

Authors:  Ming Li; Ying Wang; Yongsheng Song; Renge Bu; Bo Yin; Xiang Fei; Qizhen Guo; Bin Wu
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

Review 7.  5-hydroxymethylcytosine: a new insight into epigenetics in cancer.

Authors:  Chao Ye; Lan Li
Journal:  Cancer Biol Ther       Date:  2013-11-19       Impact factor: 4.742

Review 8.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma.

Authors:  Hong Fan; Zhu-Jiang Zhao; Jian Cheng; Xian-Wei Su; Qing-Xiang Wu; Yun-Feng Shan
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

10.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.

Authors:  Yoshimasa Saito; Yae Kanai; Michiie Sakamoto; Hidetsugu Saito; Hiromasa Ishii; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.